Physician profile
Vy Dam
NPI 1639664725
$5,817.31
in general payments reported to CMS, 2019-2025
25 companies · $2,134 in 2025
The $2,134 reported for 2025 was more than what 95% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $345 · 2022: $656 · 2023: $1,658 · 2024: $1,025 · 2025: $2,134.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,442 · Travel and Lodging: $975 · Honoraria: $400.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,441.76 |
| Travel and Lodging | $974.70 |
| Honoraria | $400.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $1,540.60 | 2023-2025 | Barostim Neo System |
| Abbott Laboratories | $906.48 | 2022-2024 | Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems, 2nd Gen Centrimag Primary Console |
| Pfizer INC. | $492.55 | 2023-2025 | |
| Becton, Dickinson and Company | $400.00 | 2025 | |
| Teva Pharmaceuticals USA, INC. | $242.42 | 2021-2023 | Uzedy |
| Ultragenyx Pharmaceutical INC. | $227.26 | 2022-2024 | Dojolvi |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $165.32 | 2022-2025 | Lifevest |
| Genzyme Corporation | $148.81 | 2023 | |
| Abiomed | $133.08 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $132.04 | 2023 | Camzyos |
| Edwards Lifesciences Corporation | $131.19 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Astrazeneca Pharmaceuticals LP | $125.00 | 2021 | |
| Neurelis, INC. | $125.00 | 2023 | Valtoco |
| Lucid Diagnostics INC. | $124.59 | 2022 | |
| Argenx US, INC. | $120.86 | 2023 | Vyvgart |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka Pharmaceutical Development & Commercialization, INC. | $120.39 | 2024 | |
| Abbvie INC. | $117.65 | 2023 | |
| Kestra Medical Technology Services, INC. | $112.83 | 2025 | Assure Wcd |
| Janssen Pharmaceuticals, INC | $104.00 | 2023 | Xarelto |
| Boston Scientific Corporation | $101.73 | 2024-2025 | Resonate El Icd Vr |
| Boehringer Ingelheim Pharmaceuticals, INC. | $99.22 | 2021 | |
| Medtronic, INC. | $63.00 | 2022 | |
| Impulse Dynamics (USA) INC. | $44.24 | 2023 | Optimizer |
| Scpharmaceuticals INC. | $21.95 | 2023 | |
| Hologic Sales and Service, LLC | $17.10 | 2023 | Fluent Fluid Management System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vy Dam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.